Antiretroviral Therapy for Acute HIV Infection.
Phase of Trial: Phase III
Latest Information Update: 03 Feb 2017
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc; Raltegravir
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms AAHIV
- 10 Jun 2017 Biomarkers information updated
- 25 Jan 2017 Planned number of patients changed from 150 to 500.
- 17 Jun 2016 Results from NCT00796146 and NCT00796263 trials (n=234) published in the Clinical Infectious Diseases